Stock listing

Mindmaze Therapeutics Holding Sa

Selected listing: V6M · MUN · EUR · DE

Mindmaze Therapeutics Holding Sa (Munich:V6M), Health Technology. Latest release Sep 17, 2026: MindMaze Therapeutics Announces MindMotion Lite to Expand…

V6M:MUNEURDEUpdated September 19, 2026

Ticker: Munich:V6M
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Munich
Currency: EUR

Latest news from Mindmaze Therapeutics Holding Sa

MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based Neurorehabilitation

September 17, 2026

MindMaze Therapeutics to Present at Upcoming Investor and Industry Conferences

September 1, 2026

MindMaze Therapeutics Reports 2026 Half-Year Results and Corporate Update

August 27, 2026

MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor

August 12, 2026

MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing

August 10, 2026

All Mindmaze Therapeutics Holding Sa news →

Research Mindmaze Therapeutics Holding Sa

Mindmaze Therapeutics Holding Sa company profile

View the public company page for Mindmaze Therapeutics Holding Sa on 6ix.

Mindmaze Therapeutics Holding Sa news

Read company news and market updates connected to Mindmaze Therapeutics Holding Sa.

Mindmaze Therapeutics Holding Sa investor events

Find investor webinars, events, and replay context for Mindmaze Therapeutics Holding Sa.